[1] |
Picardo M, Dell′Anna ML, Ezzedine K, et al. Vitiligo[J]. Nat Rev Dis Primers, 2015,1:15011. doi: 10.1038/nrdp.2015.11.
|
[2] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021,13(4):315⁃409. doi: 10. 3760/cma.j.cn115791⁃20210221⁃00095.
|
[3] |
Chang HC, Lin MH, Huang YC, et al. The association between vitiligo and diabetes mellitus: a systematic review and meta⁃analysis[J]. J Am Acad Dermatol, 2019,81(6):1442⁃1445. doi: 10.1016/j.jaad.2019.06.022.
|
[4] |
Al Houssien AO, Al Houssien RO, Al Ajroush W, et al. Chronic diseases among vitiligo patients. A case control study[J]. Saudi Med J, 2017,38(4):400⁃404. doi: 10.15537/smj.2017.4.17551.
|
[5] |
张雅君, 刘玲, 李强, 等. 白癜风10821例伴发疾病的研究与分析[J]. 中国美容医学, 2012,21(11):1589⁃1592. doi: 10. 3969/j.issn.1008⁃6455.2012.11.055.
|
[6] |
景璟, 郑敏. 银屑病共患疾病的临床研究进展[J]. 中华皮肤科杂志, 2015,48(12):899⁃901.
|
[7] |
Walker ER, Druss BG. A public health perspective on mental and medical comorbidity[J]. JAMA, 2016,316(10):1104⁃1105. doi: 10.1001/jama.2016.10486.
|
[8] |
Janssen L, Hiligsmann M, Elissen A, et al. Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study[J]. Diabet Med, 2020,37(10):1759⁃1765. doi: 10.1111/dme.14285.
|
[9] |
Radtke MA, Schäfer I, Gajur A, et al. Willingness⁃to⁃pay and quality of life in patients with vitiligo[J]. Br J Dermatol, 2009,161(1):134⁃139. doi: 10.1111/j.1365⁃2133.2009.09091.x.
|
[10] |
Zhou X, Qiao Q, Ji L, et al. Nonlaboratory⁃based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation⁃wide diabetes survey[J]. Diabetes Care, 2013,36(12):3944⁃3952. doi: 10.2337/dc13⁃0593.
|
[11] |
欧阳平, 李小溪, 冷芬, 等. 机器学习算法在体检人群糖尿病风险预测中的应用[J]. 中华疾病控制杂志, 2021,25(7):849⁃853+868.
|
[12] |
Edeh MO, Khalaf OI, Tavera CA, et al. A classification algorithm⁃based hybrid diabetes prediction model[J]. Front Public Health, 2022,10:829519. doi: 10.3389/fpubh.2022.829519.
|
[13] |
Nomura A, Noguchi M, Kometani M, et al. Artificial intelligence in current diabetes management and prediction[J]. Curr Diab Rep, 2021,21(12):61. doi: 10.1007/s11892⁃021⁃01423⁃2.
|
[14] |
中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识(2021版)[J]. 中华皮肤科杂志, 2021,54(2):105⁃109. doi: 10.35541/cjd.20200785.
|
[15] |
孙倩, 王慧, 乔楠, 等. 成年居民膳食模式与2型糖尿病风险的关联研究[J]. 中华预防医学杂志, 2020,54(3):278⁃282. doi: 10.3760/cma.j.issn.0253⁃9624.2020.03.007.
|
[16] |
陆凤, 应丹妮, 龚巍巍, 等. 浙江省甲状腺癌患病影响因素的配对病例对照研究[J]. 中华流行病学杂志, 2018,39(10):1387⁃1393.
|
[17] |
Hamann CR, Egeberg A, Silverberg JI, et al. Association between parental autoimmune disease and atopic dermatitis in their offspring: a matched case⁃control study[J]. J Eur Acad Dermatol Venereol, 2019,33(6):1143⁃1151. doi: 10.1111/jdv. 15413.
|
[18] |
Wang L, Folsom AR, Zheng ZJ, et al. Plasma fatty acid composition and incidence of diabetes in middle⁃aged adults: the Atherosclerosis Risk in Communities (ARIC) Study[J]. Am J Clin Nutr, 2003,78(1):91⁃98. doi: 10.1093/ajcn/78.1.91.
|
[19] |
Li M, Li X, Zhao Y, et al. The burden of ischemic heart disease and type 2 diabetes mellitus attributable to diet high in sugar⁃sweetened beverages in China: an analysis for the Global Burden of Disease Study 2017[J]. J Diabetes, 2021,13(6):482⁃493. doi: 10.1111/1753⁃0407.13132.
|
[20] |
Abdulai T, Runqi T, Mao Z, et al. Preference for high dietary salt intake is associated with undiagnosed type 2 diabetes: the Henan rural cohort[J]. Front Nutr, 2020,7:537049. doi: 10.3389/fnut.2020.537049.
|
[21] |
Ye Z, Chen J, Du P, et al. Metabolomics signature and potential application of serum polyunsaturated fatty acids metabolism in patients with vitiligo[J]. Front Immunol, 2022,13:839167. doi: 10.3389/fimmu.2022.839167.
|
[22] |
Boniface K, Seneschal J, Picardo M, et al. Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy[J]. Clin Rev Allergy Immunol, 2018,54(1):52⁃67. doi: 10.1007/s12016⁃017⁃8622⁃7.
|
[23] |
Sharma YK, Bansal P, Menon S, et al. Metabolic syndrome in vitiligo patients among a semi⁃urban Maharashtrian population: a case control study[J]. Diabetes Metab Syndr, 2017,11 Suppl 1:S77⁃S80. doi: 10.1016/j.dsx.2016.12.009.
|
[24] |
Kang P, Zhang WG, Ji ZH, et al. Association between vitiligo and relevant components of metabolic syndrome: a systematic review and meta⁃analysis[J]. J Dtsch Dermatol Ges, 2022. doi: 10.1111/ddg.14717.
|
[25] |
Ataş H, Gönül M. Increased risk of metabolic syndrome in patients with vitiligo[J]. Balkan Med J, 2017,34(3):219⁃225. doi: 10.4274/balkanmedj.2016.1005.
|
[26] |
Goel A, Chiu H, Felton J, et al. T⁃cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta⁃cell lesions in phenotypic type 2 diabetes[J]. Diabetes, 2007,56(8):2110⁃2115. doi: 10.2337/db06⁃0552.
|
[27] |
Brooks⁃Worrell BM, Reichow JL, Goel A, et al. Identification of autoantibody⁃negative autoimmune type 2 diabetic patients[J]. Diabetes Care, 2011,34(1):168⁃173. doi: 10.2337/dc10⁃0579.
|
[28] |
周红, 向明. 胰岛自身免疫与2型糖尿病[J]. 国际内分泌代谢杂志, 2012,32(5):335⁃337. doi: 10.3760/cma.j.issn.1673⁃4157. 2012.05.015.
|
[29] |
Song E, Koo MJ, Noh E, et al. Risk of diabetes in patients with long⁃standing Graves′ disease: a longitudinal study[J]. Endocrinol Metab (Seoul), 2021,36(6):1277⁃1286. doi: 10.3803/ EnM.2021.1251.
|
[30] |
倪萍, 黄国惠, 蒲亚玲, 等. 白癜风并发自身免疫性甲状腺疾病的危险因素分析及列线图预测模型的建立[J]. 中国麻风皮肤病杂志, 2020,36(12):726⁃730.
|
[31] |
Radhakutty A, Burt MG. Management of endocrine disease: critical review of the evidence underlying management of glucocorticoid⁃induced hyperglycaemia[J]. Eur J Endocrinol, 2018,179(4):R207⁃R218. doi: 10.1530/EJE⁃18⁃0315.
|
[32] |
牛建英. 类固醇糖尿病:一个重要而易被忽视的临床问题[J]. 肾脏病与透析肾移植杂志, 2019,28(5):450⁃451.
|
[33] |
Xu Z, Chen D, Hu Y, et al. Anatomically distinct fibroblast subsets determine skin autoimmune patterns[J]. Nature, 2022,601(7891):118⁃124. doi: 10.1038/s41586⁃021⁃04221⁃8.
|
[34] |
王敬瀚. ROC曲线在临床医学诊断实验中的应用[J]. 中华高血压杂志, 2008,16(2):175⁃177.
|
[35] |
贾玉龙, 周洁, 陈颖, 等. 临床预测模型的综合评价体系研究[J]. 中国卫生统计, 2019,36(5):728⁃730+734.
|